agent is selected from the group consisting of PF-3644022, BIO-475863, MK2 III, MK2 IV and mixtures thereof. PF-3644022 is available for research use from Sigma Aldrich, developed by Pfizer; specifications of PF-3644022 are set forth at http://www.sigmaaldrich.com/catalog/product/sigma/pz...